NBY

NovaBay Pharmaceuticals, Inc.

1.44

USD

NBY Earnings Reports

Positive Surprise Ratio

NBY beat 15 of 36 last estimates.

42%

Next Report

Next Week

Date of Next Report

Mar 31, 2026

Estimate for Q4 25 (Revenue/ EPS)

$3.03M

-$0.20

Implied change from Q-- -- (Revenue/ EPS)

Implied change from Q4 24 (Revenue/ EPS)

NovaBay Pharmaceuticals, Inc. earnings per share and revenue

On --, NBY reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.

Looking ahead to Q4 25, 2 analysts forecast an EPS of -0.20 USD, with revenue projected to reach 3.03 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Talphera, Inc. Common Stock

Report Date

Mar 23, 2026 For Q4 25

Estimate

-$0.08

Actual

-$0.06

Surprise

+26.47%

Theravance Biopharma, Inc.

Report Date

Mar 19, 2026 For Q4 25

Estimate

$1.24

Actual

$0.21

Surprise

-83.12%

Relmada Therapeutics, Inc. Common Stock

Report Date

Mar 19, 2026 For Q4 25

Estimate

-$0.14

Actual

-$0.28

Surprise

-103.08%

Context Therapeutics Inc. Common Stock

Report Date

Mar 23, 2026 For Q4 25

Estimate

-$0.10

Actual

-$0.14

Surprise

-29.39%

Avalo Therapeutics, Inc. Common Stock

Report Date

Mar 23, 2026 For Q4 25

Estimate

-$1.49

Actual

-$1.12

Surprise

+24.33%

Journey Medical Corporation Common Stock

Report Date

Mar 25, 2026 For Q4 25

Estimate

-$0.05

Actual

-$0.04

Surprise

+31.86%

Surrozen, Inc. Common

Report Date

Mar 30, 2026 For Q4 25

Estimate

-$1.21

Actual

Surprise

Achieve Life Sciences, Inc.

Report Date

Mar 24, 2026 For Q4 25

Estimate

-$0.27

Actual

-$0.28

Surprise

-1.12%

Pyxis Oncology, Inc. Common Stock

Report Date

Mar 23, 2026 For Q4 25

Estimate

-$0.34

Actual

-$0.28

Surprise

+15.55%

Fractyl Health, Inc. Common Stock

Report Date

Mar 24, 2026 For Q4 25

Estimate

-$0.18

Actual

$0.15

Surprise

+181.70%

FAQ

What were NovaBay Pharmaceuticals, Inc.'s earnings and revenue for the latest quarter Q-- --?

For Q-- --, NovaBay Pharmaceuticals, Inc. reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.

How did the market react to NovaBay Pharmaceuticals, Inc.'s Q-- -- earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is NovaBay Pharmaceuticals, Inc. expected to report next?

The next earning report is scheduled for Mar 31, 2026.

What are the forecasts for NovaBay Pharmaceuticals, Inc.'s next earnings report?

Based on 2 analysts, NovaBay Pharmaceuticals, Inc. is expected to report EPS of -$0.20 and revenue of $3.03M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.